tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Income Statement

Compare
2,216 Followers

Catalyst Pharma Income Statement

Last quarter (Q3 2024), Catalyst Pharma's total revenue was $128.69M, an increase of 25.33% from the same quarter last year. In Q3, Catalyst Pharma's net income was $43.88M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 398.20M$ 214.20M$ 140.83M$ 119.07M$ 102.31M
Gross Profit
$ 313.67M$ 179.81M$ 118.95M$ 102.03M$ 87.55M
Operating Expenses
$ 259.43M$ 77.97M$ 66.56M$ 60.73M$ 55.72M
Depreciation and Amortization
$ 32.88M$ 1.49M$ 484.00K$ 885.32K$ 297.73K
EBITDA
$ 119.69M$ 101.84M$ 52.38M$ 41.30M$ 31.82M
Operating Income
$ 86.81M$ 101.84M$ 52.38M$ 41.30M$ 31.82M
Other Income/Expenses
$ 7.70M$ 2.88M$ 282.00K$ 586.90K$ 1.59M
Pretax Income
$ 94.51M$ 104.72M$ 52.67M$ 41.89M$ 33.41M
Net Income
$ 71.41M$ 83.08M$ 39.48M$ 74.98M$ 31.88M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.67$ 0.80$ 0.38$ 0.72$ 0.31
Diluted EPS
$ 0.63$ 0.75$ 0.37$ 0.71$ 0.30
Weighted Average Shares Outstanding
106.28M 103.37M 103.38M 103.51M 102.94M
Weighted Average Shares Outstanding (Diluted)
113.75M 111.38M 107.80M 106.24M 106.02M
Currency in USD

Catalyst Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis